Douglas W. Blayney, MD, FASCO, Clinical researcher and breast oncologist, Professor of Medicine at Stanford University. In this video, he…
Browsing: Breast Cancer
Breast Cancer Treatment Resources
Breast cancer treatment options are evolving rapidly, and OncologyTube’s Breast Cancer Treatment category is your go-to source for the latest insights. Explore expert-led videos, clinical trial updates, and research from leading oncologists. Whether you’re seeking information on chemotherapy, immunotherapy, or surgical options, our curated content helps patients and professionals stay informed. Browse our collection to discover breakthroughs like the EMBER-3 Trial for advanced care.
Why Trust OncologyTube?
Our content features trusted experts like Dr. Saranya Chumsri, a triple-negative breast cancer specialist, ensuring credible and actionable insights. We collaborate with top institutions to bring you reliable information tailored to your needs.
Latest Breast Cancer Research
Stay updated with cutting-edge studies and trials, such as ASCO 2025 highlights on targeted therapies. Our videos break down complex topics into clear, actionable information for patients and caregivers. Learn about innovative approaches like PARP inhibitors and their impact on HER2-positive cases.
Patient and Professional Resources
OncologyTube offers tools for both patients and healthcare providers. Patients can find support resources, while professionals can access updates on clinical guidelines from sources like ASCO and ESMO. Explore our video library for interviews with experts discussing real-world treatment challenges and solutions.
Explore More
Check out related content like Dr. Chumsri’s video on triple-negative breast cancer or dive into our Immunotherapy Category for complementary insights. For trusted guidelines, visit the National Cancer Institute or ASCO.
Debra A. Patt, MD, Ph.D., MBA, FASCO, is a practicing oncologist and breast cancer specialist in Austin, Texas, and an…
Debra A. Patt, MD, Ph.D., MBA, FASCO, is a practicing oncologist and breast cancer specialist in Austin, Texas, and an…
Ian Krop, MD, Ph.D., Associate Cancer Center Director for Clinical Research; Yale Cancer Center. In this video, he speaks about…
Ian Krop, MD, Ph.D., Associate Cancer Center Director for Clinical Research; Yale Cancer Center. In this video, he speaks about…
Maria Soledad Sosa, Ph.D., Assistant Professor of Pharmacological Sciences, and Oncological Sciences, at The Tisch Cancer Institute at Mount Sinai.…
Maria Soledad Sosa, Ph.D., Assistant Professor of Pharmacological Sciences, and Oncological Sciences, at The Tisch Cancer Institute at Mount Sinai.…
Dennis J. Slamon, MD, Director of Clinical/Translational Research, University of California, Los Angeles Jonsson Comprehensive Cancer Center. In this video,…
Dennis J. Slamon, MD, Director of Clinical/Translational Research, University of California, Los Angeles Jonsson Comprehensive Cancer Center. In this video,…
Laura Alder, MD, Hematology-Oncology Fellow at Duke University Health System. In this video, she speaks about the AACR 2022 Abstract…
Laura Alder, MD, Hematology-Oncology Fellow at Duke University Health System. In this video, she speaks about the AACR 2022 Abstract…
Michael J. Donovan, MD, Ph.D., Research Professor of Pathology, Molecular, and Cell-Based Medicine at Icahn School of Medicine at Mount…
Michael J. Donovan, MD, Ph.D., Research Professor of Pathology, Molecular, and Cell-Based Medicine at Icahn School of Medicine at Mount…
Javier Cortés, MD, Ph.D., Founder, and director of the International Breast Cancer Center (IBCC), in Madrid, Spain. Dr. Javier Cortés…
Javier Cortés, MD, Ph.D., Founder, and director of the International Breast Cancer Center (IBCC), in Madrid, Spain. Dr. Javier Cortés…
Yuan Yuan, Ph.D., medical oncologist, City of Hope, and Colt Egelston, Ph.D., assistant research professor at the Beckman Research Institute…
Yuan Yuan, Ph.D., medical oncologist, City of Hope, and Colt Egelston, Ph.D., assistant research professor at the Beckman Research Institute…
Mark LaBarge, Ph.D., professor, Department of Population Sciences, City of Hope. In this video, he speaks about the AACR 2022…
Mark LaBarge, Ph.D., professor, Department of Population Sciences, City of Hope. In this video, he speaks about the AACR 2022…
Mariya Rozenblit, MD, Instructor of Medicine (Medical Oncology) and cares for patients with a clinical focus on breast cancer from…
Mariya Rozenblit, MD, Instructor of Medicine (Medical Oncology) and cares for patients with a clinical focus on breast cancer from…
Prof. Dr. Enrique Estrada-Lobato, IAEA Nuclear Medicine Physician. In this video, he speaks about the IAEA’s Support of breast cancer…
Prof. Dr. Enrique Estrada-Lobato, IAEA Nuclear Medicine Physician. In this video, he speaks about the IAEA’s Support of breast cancer…
Debu Tripathy, MD, Professor and Chairman, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD…
Debu Tripathy, MD, Professor and Chairman, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD…
Charles E. Geyer, Jr., MD, FACP, Principal Investigator for NSABP B-55 Portion of the OlympiA Trial, Medical Oncologist & Breast…
Charles E. Geyer, Jr., MD, FACP, Principal Investigator for NSABP B-55 Portion of the OlympiA Trial, Medical Oncologist & Breast…
Kevin Kalinsky, MD, MS, Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Louisa and Rand…
Kevin Kalinsky, MD, MS, Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Louisa and Rand…
Prof. dr. Xavier Pivot, MD, Ph.D., Professor of Oncology, General Director of Paul Strauss anti-Cancer Center, Chairman of the Regional…
Prof. dr. Xavier Pivot, MD, Ph.D., Professor of Oncology, General Director of Paul Strauss anti-Cancer Center, Chairman of the Regional…
Philippe Bedard, MD is an Associate Professor of Medicine at the University of Toronto. He is a Staff Medical Oncologist…
Philippe Bedard, MD is an Associate Professor of Medicine at the University of Toronto. He is a Staff Medical Oncologist…
M. Michele Blackwood, MD, FACS, Chief, Section of Breast Surgery, Rutgers Cancer Institute of New Jersey, Northern Regional Director of…
M. Michele Blackwood, MD, FACS, Chief, Section of Breast Surgery, Rutgers Cancer Institute of New Jersey, Northern Regional Director of…
Mark Pegram, MD, is the Suzy Yuan-Huey Hung Endowed Professor of Medical Oncology at the Stanford Cancer Institute. He currently…
Mark Pegram, MD, is the Suzy Yuan-Huey Hung Endowed Professor of Medical Oncology at the Stanford Cancer Institute. He currently…
Michael Alvarado, MD, Professor of Surgery, Division of Surgical Oncology, Director, Breast Surgery Oncology Fellowship at University of California San…
Michael Alvarado, MD, Professor of Surgery, Division of Surgical Oncology, Director, Breast Surgery Oncology Fellowship at University of California San…
Aditya Bardia, MD, MPH, Director of Breast Cancer Research, Mass General Cancer Center, Attending Physician, Mass General Cancer Center, Associate…
Aditya Bardia, MD, MPH, Director of Breast Cancer Research, Mass General Cancer Center, Attending Physician, Mass General Cancer Center, Associate…
Chirag Shah, MD, Director of Breast Radiation Oncology and Director of Clinical Research in the Department of Radiation Oncology at…
Chirag Shah, MD, Director of Breast Radiation Oncology and Director of Clinical Research in the Department of Radiation Oncology at…
Charles Loprinzi, MD, Regis Professor of Breast Cancer Research, Medical Oncologist at Mayo Foundation for Medical Education and Research at…
Charles Loprinzi, MD, Regis Professor of Breast Cancer Research, Medical Oncologist at Mayo Foundation for Medical Education and Research at…
Chirag Shah, MD, Director of Breast Radiation Oncology and Director of Clinical Research in the Department of Radiation Oncology at…
Chirag Shah, MD, Director of Breast Radiation Oncology and Director of Clinical Research in the Department of Radiation Oncology at…
Anees Chagpar, MD, MBA, MPH, FACS, FRCS(C), Professor of Surgery (Oncology), Yale University School of Medicine. In this video, she…
Anees Chagpar, MD, MBA, MPH, FACS, FRCS(C), Professor of Surgery (Oncology), Yale University School of Medicine. In this video, she…
Halle Moore, MD, Associate Professor, Department of Medicine, School of Medicine, Member, Population and Cancer Prevention Program, Case Comprehensive Cancer…
Halle Moore, MD, Associate Professor, Department of Medicine, School of Medicine, Member, Population and Cancer Prevention Program, Case Comprehensive Cancer…
Adam Brufsky, MD, Ph.D., Professor of medicine at the University of Pittsburgh School of Medicine and also serves as the…
Adam Brufsky, MD, Ph.D., Professor of medicine at the University of Pittsburgh School of Medicine and also serves as the…
Wendy Chen, MD, MPH, Assistant Professor, Medicine, Harvard Medical School, Senior Physician, Breast Oncology Center, Dana-Farber Cancer Institute. In this…
Wendy Chen, MD, MPH, Assistant Professor, Medicine, Harvard Medical School, Senior Physician, Breast Oncology Center, Dana-Farber Cancer Institute. In this…
Chirag Shah, MD, Director of Breast Radiation Oncology and Director of Clinical Research in the Department of Radiation Oncology at…
Chirag Shah, MD, Director of Breast Radiation Oncology and Director of Clinical Research in the Department of Radiation Oncology at…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Angela DeMichele, MD, MSCE, Co-Leader, Breast Cancer Research Program, Director, Breast Cancer Clinical Trials Unit, Co-Director, 2-PREVENT Breast Cancer Translational…
Angela DeMichele, MD, MSCE, Co-Leader, Breast Cancer Research Program, Director, Breast Cancer Clinical Trials Unit, Co-Director, 2-PREVENT Breast Cancer Translational…
The discussion was on Tuesday, December 7, 2021Optimizing Immunotherapy in Triple-Negative Breast Cancer: Novel Predictive Biomarkers and Blood-Basted Efficacy MonitoringSpeaker…
The discussion was on Tuesday, December 7, 2021Optimizing Immunotherapy in Triple-Negative Breast Cancer: Novel Predictive Biomarkers and Blood-Basted Efficacy MonitoringSpeaker…
The discussion was on Tuesday, December 7, 2021Optimizing Immunotherapy in Triple-Negative Breast Cancer: Novel Predictive Biomarkers and Blood-Basted Efficacy MonitoringSpeakers…
The discussion was on Tuesday, December 7, 2021Optimizing Immunotherapy in Triple-Negative Breast Cancer: Novel Predictive Biomarkers and Blood-Basted Efficacy MonitoringSpeakers…
The discussion was on Tuesday, December 7, 2021Optimizing Immunotherapy in Triple-Negative Breast Cancer: Novel Predictive Biomarkers and Blood-Basted Efficacy MonitoringSpeaker…
The discussion was on Tuesday, December 7, 2021Optimizing Immunotherapy in Triple-Negative Breast Cancer: Novel Predictive Biomarkers and Blood-Basted Efficacy Monitoring Speakers…
Adam M. Brufsky, MD, Ph.D., Professor of Medicine, Associate Chief, Division of Hematology/Oncology, Co-Director, Comprehensive Breast Cancer Center, Associate Director,…
Adam M. Brufsky, MD, Ph.D., Professor of Medicine, Associate Chief, Division of Hematology/Oncology, Co-Director, Comprehensive Breast Cancer Center, Associate Director,…
Adam M. Brufsky, MD, Ph.D., Professor of Medicine, Associate Chief, Division of Hematology/Oncology, Co-Director, Comprehensive Breast Cancer Center, Associate Director,…
Dr. Stephen Malamud is the regional director of medical oncology at Nuvance Health. He is a board-certified and fellowship-trained physician…
Dr. Stephen Malamud is the regional director of medical oncology at Nuvance Health. He is a board-certified and fellowship-trained physician…
Javier Cortés, MD, Ph.D., Founder, and director of the International Breast Cancer Center (IBCC), in Madrid, Spain. Dr. Javier Cortés…
Javier Cortés, MD, Ph.D., Founder, and director of the International Breast Cancer Center (IBCC), in Madrid, Spain. Dr. Javier Cortés…
Sara Tolaney, MD from Dana Farber Cancer Institute speaks about the SABCS 2021 Presentation – Heterogeneity in treatment outcomes for…
Sara Tolaney, MD from Dana Farber Cancer Institute speaks about the SABCS 2021 Presentation – Heterogeneity in treatment outcomes for…
Sara A. Hurvitz, MD, Assistant Professor of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA speaks about…
Sara A. Hurvitz, MD, Assistant Professor of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA speaks about…
Terry Mamounas, MD, MPH, FACS from Orlando Health Cancer Institute speaks about the SABCS 2021 Presentation – Refining Axillary Management…
Terry Mamounas, MD, MPH, FACS from Orlando Health Cancer Institute speaks about the SABCS 2021 Presentation – Refining Axillary Management…
David Spiegel, MD from Stanford University speaks about the SABCS Presentation – Hypnosis and Mindfulness.Go to the links below to…
David Spiegel, MD from Stanford University speaks about the SABCS Presentation – Hypnosis and Mindfulness.Go to the links below to…
Erika P. Hamilton, MD, Director, Breast Cancer and Gynecologic Cancer Research, Sarah Cannon Research Institute at Tennessee Oncology speak about…
Erika P. Hamilton, MD, Director, Breast Cancer and Gynecologic Cancer Research, Sarah Cannon Research Institute at Tennessee Oncology speak about…
Elisha Hughes, Ph.D., Director of Research Biostatistics at Myriad Genetics, Inc. speaks about the SABCS Abstract – P2-11-21 Integration of…
Elisha Hughes, Ph.D., Director of Research Biostatistics at Myriad Genetics, Inc. speaks about the SABCS Abstract – P2-11-21 Integration of…
Kirsten Timms, Ph.D., VP Biomarker Discovery at Myriad Genetics Inc speaks about SABCS 2021 Abstract – P5-13-09 Identifying homologous recombination…
Kirsten Timms, Ph.D., VP Biomarker Discovery at Myriad Genetics Inc speaks about SABCS 2021 Abstract – P5-13-09 Identifying homologous recombination…
Pedram Razavi, MD, Ph.D. from Memorial Sloan Kettering Cancer Center speaks about SABCS 2021 Presentation – Challenges in early detection…
Pedram Razavi, MD, Ph.D. from Memorial Sloan Kettering Cancer Center speaks about SABCS 2021 Presentation – Challenges in early detection…
Shyamala Maheswaran, Ph.D. from Massachusetts General Hospital speaks about the SABCS Presentation – Single Cell Analysis Of Circulating Tumor Cells.
Shyamala Maheswaran, Ph.D. from Massachusetts General Hospital speaks about the SABCS Presentation – Single Cell Analysis Of Circulating Tumor Cells.
Professor Peter Schmid, MD, Ph.D. from Bart’s Cancer Institute, Queen Mary University of London speaks about SABCS 2021 Review of…
Professor Peter Schmid, MD, Ph.D. from Bart’s Cancer Institute, Queen Mary University of London speaks about SABCS 2021 Review of…
Professor Patricia Ganz, MD, Director of Cancer Prevention and Control Research at the Jonsson Comprehensive Cancer Center speaks about the…
Professor Patricia Ganz, MD, Director of Cancer Prevention and Control Research at the Jonsson Comprehensive Cancer Center speaks about the…
Dr. Heather Han is a medical oncologist and the Research Director of the Moffitt Cancer Center’s Department of Breast Oncology.…
Dr. Heather Han is a medical oncologist and the Research Director of the Moffitt Cancer Center’s Department of Breast Oncology.…
Douglas W. Blayney, MD, is a professor of medicine (oncology) at Stanford University and the former Medical Director of Stanford…
Douglas W. Blayney, MD, is a professor of medicine (oncology) at Stanford University and the former Medical Director of Stanford…
Irene Wapnir, MD from Stanford University School of Medicine speaks about SABCS Abstract OT1-09-01 A randomized study comparing surgical excision…
Irene Wapnir, MD from Stanford University School of Medicine speaks about SABCS Abstract OT1-09-01 A randomized study comparing surgical excision…
Charles E. Geyer, Jr., MD, FACP, Deputy Director of the Houston Methodist Cancer Center, and Study Co-Chair speaks about SABCS…
Charles E. Geyer, Jr., MD, FACP, Deputy Director of the Houston Methodist Cancer Center, and Study Co-Chair speaks about SABCS…
Meredith M. Regan, ScD, Associate Professor of Medicine, Dana-Farber Cancer Institute/Harvard Medical School speaks about the SABCS 2021 Abstract -…
Meredith M. Regan, ScD, Associate Professor of Medicine, Dana-Farber Cancer Institute/Harvard Medical School speaks about the SABCS 2021 Abstract -…
Nadia Harbeck, MD, PhD, is head of the Breast Center and holds the chair for Conservative Oncology at the Dept.…
Nadia Harbeck, MD, PhD, is head of the Breast Center and holds the chair for Conservative Oncology at the Dept.…
Gabriel Aleixo, MD from the Cleveland Clinic speaks about the SABCS Abstract – P1-08-04 The impact of sarcopenia and sarcopenic…
Gabriel Aleixo, MD from the Cleveland Clinic speaks about the SABCS Abstract – P1-08-04 The impact of sarcopenia and sarcopenic…
Monica Morrow, MD from Memorial Sloan Kettering Cancer Center speaks about the SABCS 2021 Presentation Is less (or more) axillary…
Monica Morrow, MD from Memorial Sloan Kettering Cancer Center speaks about the SABCS 2021 Presentation Is less (or more) axillary…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, has presented GRACE with…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video…
Chirag Shah, MD, Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic speaks about the ASTRO 2021 Abstract – 66…
Chirag Shah, MD, Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic speaks about the ASTRO 2021 Abstract – 66…
Michelina Cairo, MD from Texas Oncology speaks about ESMO 2021 Abstract LBA1 – Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1)…
Michelina Cairo, MD from Texas Oncology speaks about ESMO 2021 Abstract LBA1 – Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1)…
Debra Patt, MD, Ph.D., MBA, FASCO, Executive Vice President at Texas Oncology a member of The US Oncology Network, Professor…
Debra Patt, MD, Ph.D., MBA, FASCO, Executive Vice President at Texas Oncology a member of The US Oncology Network, Professor…
Stephanie Patterson, MD, FACR, FSBI, Clinical Professor, Radiology, Division of Breast Imaging, University of Michigan, Michigan Medicine speaks about Tomosynthesis…
Stephanie Patterson, MD, FACR, FSBI, Clinical Professor, Radiology, Division of Breast Imaging, University of Michigan, Michigan Medicine speaks about Tomosynthesis…
Mario Campone, MD, Ph.D., Professor, Medical Oncologist, Director General of the Institut de Cancérologie de l’Ouest (ICO), René Gauducheau, St…
Mario Campone, MD, Ph.D., Professor, Medical Oncologist, Director General of the Institut de Cancérologie de l’Ouest (ICO), René Gauducheau, St…
Saura Manich from the Department of Medical Oncology, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron speaks about…
Saura Manich from the Department of Medical Oncology, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron speaks about…
Kevin Punie, MD Medical Oncologist Specialized in treatment of TNBC from the University Hospitals Leuven, Belgium speaks about ESMO 2021…
Overview of the ASCENT Trial and Trodelvy The ASCENT Trial (NCT02574455) is a Phase III study that compares Trodelvy (Sacituzumab…
Mark LaBarge, Ph.D., professor in City of Hope’s Department of Population Sciences, and Sundus Shalabi, Ph.D. candidate at the City…
Mark LaBarge, Ph.D., professor in City of Hope’s Department of Population Sciences, and Sundus Shalabi, Ph.D. candidate at the City…
Mark Pegram, MD the Susy Yuan-Huey Hung Professor, Medicine – Oncology, Stanford Hospital, and Clinics speaks about ESMO 2021 Abstract…
Mark Pegram, MD the Susy Yuan-Huey Hung Professor, Medicine – Oncology, Stanford Hospital, and Clinics speaks about ESMO 2021 Abstract…
Hope S. Rugo, MD, Professor, Department of Medicine (Hematology/Oncology); and Director, Breast Oncology and Clinical Trials Education, UCSF Helen Dillard…
Hope S. Rugo, MD, Professor, Department of Medicine (Hematology/Oncology); and Director, Breast Oncology and Clinical Trials Education, UCSF Helen Dillard…
Kent Hoskins, MD, Co-Leader of the Breast Cancer Research Group and Director of Cancer Genetics at the University of Illinois…
Professor Peter Schmid, FRCP, MD, Ph.D., Professor of Cancer Medicine and Lead of the Centre of Experimental Cancer Medicine at…
Justin Balko, PharmD, Ph.D. from Vanderbilt University Medical Center speaks about Tumor-specific major histocompatibility-II expression predicts benefit to anti-PD-1/L1 therapy…
Monica Swahn, Ph.D. from the International Consortium for Advancing Research on Triple-Negative Breast Cancer, Department of Population Health Sciences, Georgia…
Kathryn Schmitz, Ph.D., MPH, a researcher at the Penn State Cancer Institute who chaired the ACSM’s roundtables – speaks about…
Laura Esserman, MD, MBA, Professor of Surgery and Radiology is a surgeon and breast cancer oncology specialist practicing at the…
Laura Esserman, MD, MBA, Professor of Surgery and Radiology is a surgeon and breast cancer oncology specialist practicing at the…
Aditya Bardia, MD, MPH, Director of Breast Cancer Research, Mass General Cancer Center, Harvard Medical School speaks about ASCO 2021…
Kathryn Schmitz, Ph.D., MPH, a researcher at the Penn State Cancer Institute who chaired the ACSM’s roundtables – speaks about…
Anant Madabhushi, Ph.D., the Donnell Institute Professor of Biomedical Engineering at Case Western Reserve, head of the Center for Computational…
Monica Swahn, Ph.D. from the International Consortium for Advancing Research on Triple-Negative Breast Cancer, Department of Population Health Sciences, Georgia…
Professor Peter Schmid, FRCP, MD, Ph.D., Professor of Cancer Medicine and Lead of the Centre of Experimental Cancer Medicine at…
Adam Brufsky, M.D., Ph.D. from the Magee-Womens Cancer Program, part of the UPMC Hillman Cancer Center speaks about the ASCO…
Debra Pratt, MD a Breast Surgeon at Cleveland Clinicspeaks about Breast Cancer: Finishing Treatment Soon After Diagnosis Increases Survival.Link to…
Josephine Lopes Cardozo, Ph.D. from the Netherlands Cancer Institute speaks about the ASCO 2021 Abstract – Outcome of patients with…
Aditya Bardia, MD, MPH, Director of Breast Cancer Research, Mass General Cancer Center, Harvard Medical School speaks about ASCO 2021…
Chan Shen, Ph.D., Associate Professor, Department of Surgery Chief, Division of Outcomes, Research and Quality, The Pennsylvania State University speaks…
Kent Hoskins, MD, Co-Leader of the Breast Cancer Research Group and Director of Cancer Genetics at the University of Illinois…
Charles E. Geyer, Jr., MD, FACP, Deputy Director of the Houston Methodist Cancer Center, and Study Co-Chair speaks about ASCO…
Nima Sharifi, MD, director of Cleveland Clinic’s Genitourinary Malignancies Research Center speaks about ASCO 2021 – Abstract – Adrenal-permissive HSD3B1…
Holly J. Pederson, MD, Director Medical Breast Services, Cleveland Clinic, Associate Professor of Medicine, CCLCM speaks about the ASCO 2021…
Connie Lehman, MD, Ph.D., Diagnostic Radiologist, Chief, Breast Imaging Massachusetts General Hospital speaks about These Doctors Are Using AI to…
Laura van ’t Veer, Ph.D., Co-Leader, Breast Oncology Program and Director, Applied Genomics at UCSF Helen Diller Family Comprehensive Cancer…
Matteo Lambertini, MD, Ph.D. from San Martino Hospital Genoa and the University of Genoa speaks about the Exploratory Analysis: Unexpected…
Aditya Bardia, MD, MPH from Massachusetts General Hospital discusses SAR439859 Plus Palbociclib as First Line Therapy for Patients With ER(+)…
Drs. Susan Love and Stephanie Graff join Drs. Aggarwal and West as they discuss the origins of the Love Foundation,…
Cesar A. Santa-Maria, MD MSCI from Johns Hopkins speaks about the PRISMM Study – Patient Response to Immunotherapy Using Spliceosome…
Doreen M. Agnese, MD of The OSU Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute and/or Yale…
William Gradishar, MD, FASCO, FACP from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University speaks about Updates to…
Erica L. Mayer, MD, MPH of the Dana-Farber Cancer Institute discusses Palbociclib with adjuvant endocrine therapy in early breast cancer…
Joanne Mortimer, MD from the City of Hope speaks about Breast Cancer: Her Experience, Research, And The Current Treatment LandscapeLink…
Vered Stearns, MD of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins discusses Taking an individualized approach to preventing…
Teresa Klinowska, Ph.D. Global Product Leader, Late Stage Oncology at AstraZeneca discussed the SABCS 20 abstract – SERENA-1 Phase I…
Helene Rundqvist of the Karolinska Institutet speaks about Cytotoxic T-cells mediate exercise-induced reductions in tumor growth.An abstract:Exercise has a large…
Antonio Llombart-Cussac, MD, Ph.D. Â founding partner of Medica Scientia Innovation Research (MedSIR) and the Hospital Arnau de Vilanova speaks about…
Antonio Llombart-Cussac, MD, Ph.D. founding partner of Medica Scientia Innovation Research (MedSIR) and the Hospital Arnau de Vilanova explains the…
Erika P. Hamilton, MD Director, Breast Cancer and Gynecologic Cancer Research Program, Sarah Cannon Research Institute at Tennessee Oncology discussed…
Charles L. Shapiro MD, FASCO, Professor of Medicine, Hematology, Medical Oncology and Director of Translational Breast Cancer Research Icahn School…
Gerrit-Jan Liefers, MD of Leiden University Medical Center discusses the SABCS 2020 Abstract – The 70-gene signature (MammaPrint) accurately predicts…
Frankie Ann Holmes, MD, FACP from Texas Oncology-US Oncology Research speaks about Puma Biotechnology Presents Final Overall Survival Analysis from…
Pat Whitworth, MD of the Nashville Breast Center discusses the 5-year outcomes in the NBRST trial: preoperative MammaPrint and BluePrint…
Stephanie A. Cohen, MS, LCGC from Ascension St. Vincent discusses the ACCC/ASCO 2020 abstract – [Abstract #1526] BRCA Testing Concordance…
Hope Rugo, MD of the University of California San Francisco speaks about the SABCS abstract – FDA Approves Merck’s KEYTRUDA®…
Chirag Shah, MD from the Cleveland Clinic discusses the SABCS 2020 abstract – DCIS biosignature reclassified patients who met RTOG…
Yuan Yuan, M.D., Ph.D., Medical Oncologist at the City of Hope discusses the SABCS 2020 abstract – Phase I study…
Erika J. Crosby, Ph.D. Department of Surgery at Duke University Medical Center and Melinda Telli, MD Medical Oncologist at Stanford…
Scott Howell, DO, MPH & TM, CPE from Echosens discusses Underlying nonalcoholic fatty liver disease is a significant factor for…
Shahid Gilani, MD from University Hospital Of North Midlands discusses the abstract Palbociclib in real world practice before and during…
Aditya Bardia, MD, MPH of Massachusetts General Hospital discusses the Natera Announces Collaboration with Massachusetts General Hospital for a Prospective…
Aditya Bardia, MD, MPH of Dana-Farber Cancer Institute speaks about ESMO 20 ASCENT: A randomized phase III study of sacituzumab…
Angel A. Rodriguez, MD, Oncology Medical Director of Natera speaks about Natera Announces Collaboration with Massachusetts General Hospital for a…
Erika P. Hamilton, MD Director, Breast Cancer and Gynecologic Cancer Research Program, Sarah Cannon Research Institute at Tennessee Oncology speaks…
Murray Brunt, MBBS, FRCR, FRCP The Institute of Cancer discusses an article in The Journal of Clinical Oncology entitled Ten-Year…
Paola Nix, Ph.D. at Myriad Genetics discusses an ASCO 2020 abstract entitled Functional RNA Studies Are a Useful Tool in…
Jeff Ross, MD at Foundation Medicine discusses an ASCO 2020 abstract entitled Clinically aggressive malignancies associated with STK11 germline mutations…
Charles Edward Geyer, MD Houston Methodist discusses the ASCO 2020 abstract entitled Biomarker data from KATHERINE: A phase III study…
In this episode of The Onco’Zine Brief, Peter Hofland talks with Thorsten Sperber, Global Head Medical Affairs at Immunomedics. Hofland…
In this episode of The Onco’Zine Brief, recorded during the 42nd San Antonio Breast Cancer Symposium (SABCS) held December 10…
In this edition of The Onco’Zine Brief, recorded during the 42nd San Antonio Breast Cancer Symposium (SABCS), held December 10…
Neelima Denduluri, MD @ndenduluri1 of Virginia Cancer Specialists @VCSpecialists discusses CDK 4/6 drug target activation mapping of HR+/HER2- metastatic breast…
Adam Brufsky, MD, PhD of University of Pittsburgh Cancer Institute discusses the MINDACT and HER2 guidelines in genomic profiling for…
Adam Brufsky, MD, PhD of University of Pittsburgh Cancer Institute discusses the MINDACT and HER2 guidelines in genomic profiling for…
Nancy U. Lin, MD of Dana-Farber Cancer Institute @DanaFarber discusses tucatinib vs. placebo added to trastuzumab and capecitabine for patients…
Nancy U. Lin, MD of Dana-Farber Cancer Institute @DanaFarber discusses tucatinib vs. placebo added to trastuzumab and capecitabine for patients…
Cathy L. Graham, MD of Winship Cancer Institute @WinshipAtEmory discusses basal subtype and clinical estrogen receptor status of genomically basal…
Cathy L. Graham, MD of Winship Cancer Institute @WinshipAtEmory discusses basal subtype and clinical estrogen receptor status of genomically basal…
Cathy L. Graham, MD of Winship Cancer Institute @WinshipAtEmory discusses basal subtype and clinical estrogen receptor status of genomically basal…
Hatem Soliman, MD of Moffitt Cancer Center @MoffittResearch discusses at the 12-chemokine gene expression score in breast cancer patients treated…
Hatem Soliman, MD of Moffitt Cancer Center @MoffittResearch discusses at the 12-chemokine gene expression score in breast cancer patients treated…
Hatem Soliman, MD of Moffitt Cancer Center @MoffittResearch discusses at the 12-chemokine gene expression score in breast cancer patients treated…
Cynthia X. Ma, MD of Washington University School of Medicine @WUSTLmed discusses neoadjuvant endocrine treatment (NET) approaches for clinical stage…
Cynthia X. Ma, MD of Washington University School of Medicine @WUSTLmed discusses neoadjuvant endocrine treatment (NET) approaches for clinical stage…
Daniel Vorobiof, MD of Belong.Life @Belong_Life discusses real-world data of physician’s advice on BRCA genetic testing for ovary and breast…
Daniel Vorobiof, MD of Belong.Life @Belong_Life discusses real-world data of physician’s advice on BRCA genetic testing for ovary and breast…
Daniel Vorobiof, MD of Belong.Life @Belong_Life discusses real-world data of physician’s advice on BRCA genetic testing for ovary and breast…
Andrew Foxley, BA of AstraZeneca @AstraZeneca discusses a phase III trial of capivasertib and paclitaxel in first-line treatment of patients…
Andrew Foxley, BA of AstraZeneca @AstraZeneca discusses a phase III trial of capivasertib and paclitaxel in first-line treatment of patients…
Andrew Foxley, BA of AstraZeneca @AstraZeneca discusses a phase III trial of capivasertib and paclitaxel in first-line treatment of patients…
Andrew Foxley, BA of AstraZeneca @AstraZeneca discusses a phase III trial of capivasertib and paclitaxel in first-line treatment of patients…
Jennifer Crozier, MD of Baptist Health @BaptistHealthSA discusses the FLEX real-world data platform explores new gene expression profiles and investigator-initiated…
Jennifer Crozier, MD of Baptist Health @BaptistHealthSA discusses the FLEX real-world data platform explores new gene expression profiles and investigator-initiated…
Jennifer Crozier, MD of Baptist Health @BaptistHealthSA discusses the FLEX real-world data platform explores new gene expression profiles and investigator-initiated…
Nadine Tung, MD of Dana Farber/Harvard Cancer Center @DanaFarber @Harvard discusses a phase II study of olaparib monotherapy in metastatic…
Nadine Tung, MD of Dana Farber/Harvard Cancer Center @DanaFarber @Harvard discusses a phase II study of olaparib monotherapy in metastatic…
Nadine Tung, MD of Dana Farber/Harvard Cancer Center @DanaFarber @Harvard discusses a phase II study of olaparib monotherapy in metastatic…
Prof. Laura Van ‘T Veer, Ph.D., Cheif Research Officer (CRO) and Co-Founder of Agendia and UCSF Helen Diller Family Cancer…
Prof. Laura Van ‘T Veer, Ph.D., Cheif Research Officer (CRO) and Co-Founder of Agendia and UCSF Helen Diller Family Cancer…
Prof. Laura Van ‘T Veer, Ph.D., Cheif Research Officer (CRO) and Co-Founder of Agendia and UCSF Helen Diller Family Cancer…
Jame Abraham, MD @jamecancerdoc of Cleveland Clinic @ClevelandClinic discusses at this year’s virtual ASCO the phase I open label dose…
Jame Abraham, MD @jamecancerdoc of Cleveland Clinic @ClevelandClinic discusses at this year’s virtual ASCO the phase I open label dose…
Suneel Kamath, MD @SKamath_MD of Cleveland Clinic @ClevelandClinic discusses the effect of shorter time to treatment on survival in rural…
Suneel Kamath, MD @SKamath_MD of Cleveland Clinic @ClevelandClinic discusses the effect of shorter time to treatment on survival in rural…
Suneel Kamath, MD @SKamath_MD of Cleveland Clinic @ClevelandClinic discusses the effect of shorter time to treatment on survival in rural…
Loretta Itri, MD of Immunomedics @ImmunomedicsInc discusses the FDA grants accelerated approval for Immunomedics’ trodelvy in previously-treated metastatic triple-negative breast…
Loretta Itri, MD of Immunomedics @ImmunomedicsInc discusses the FDA grants accelerated approval for Immunomedics’ trodelvy in previously-treated metastatic triple-negative breast…
Loretta Itri, MD of Immunomedics @ImmunomedicsInc discusses the FDA grants accelerated approval for Immunomedics’ trodelvy in previously-treated metastatic triple-negative breast…
Loretta Itri, MD of Immunomedics @ImmunomedicsInc discusses the FDA grants accelerated approval for Immunomedics’ trodelvy in previously-treated metastatic triple-negative breast…
Loretta Itri, MD of Immunomedics @ImmunomedicsInc discusses the FDA grants accelerated approval for Immunomedics’ trodelvy in previously-treated metastatic triple-negative breast…
Loretta Itri, MD of Immunomedics @ImmunomedicsInc discusses the FDA grants accelerated approval for Immunomedics’ trodelvy in previously-treated metastatic triple-negative breast…
Susan Galbraith, Senior Vice President and Head of Research and Early Development, Oncology R&D discusses preclinical pharmacokinetic and metabolic characterization…
Susan Galbraith, Senior Vice President and Head of Research and Early Development, Oncology R&D discusses preclinical pharmacokinetic and metabolic characterization…
Susan Galbraith, Senior Vice President and Head of Research and Early Development, Oncology R&D discusses preclinical pharmacokinetic and metabolic characterization…